the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children

Undernutrition Clinical Trial

— EHCONSGDMC  

Official title:

the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05911893
• Other study ID #: EHCONSGDMC
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 30, 2023
• Est. completion date: June 30, 2025

Study information

• Verified date: June 2023
• Source: Children's Hospital of Chongqing Medical University
• Contact: Li Chen, doctor
• Phone: 136 7762 0103
• Email: chenli2012[@]126.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to investigate the effect of high caloric oral nutritional supplements on body proportion, weight, linear growth pattern, neuropsychological development level and related health aspects (gut health, immune function, quality of life, etc.) in participants aged 1 to 3 years who are malnourished (underweight and wasting),as well as to evaluate the safety of applying high caloric oral nutritional supplements. Participants will receive nutritional education and daily high caloric oral nutritional supplements(experimental group),or will receive nutritional education and dietary instruction(control group).This study may provide data to support the development of clinical intervention strategies for malnourished Chinese children.

Description:

Background:Growth and development is an important indicator of children's health and nutritional status, and nutrition is the most important material basis for growth and development. The prevention and treatment of malnutrition in children can be achieved by choosing whole nutritional formulas for special medical purposes as oral nutritional supplements (ONS), which has been confirmed by some overseas clinical studies to promote the growth benefit of malnourished children, but no multicenter clinical study has been conducted in China on the effect of ONS on the improvement of growth and development of malnourished Chinese children.

Objective and significance: To investigate the effects of high caloric ONS on body proportion, weight, linear growth pattern, neuropsychological development level and related health aspects (gut health, immune function, quality of life, etc.) in children, as well as to evaluate the safety of applying high caloric ONS, and to provide data to support the development of clinical intervention strategies for malnourished Chinese children.

Research design:A multicenter, randomized, controlled clinical trial design method is used to randomize children who meet the inclusion criteria into the experimental and control groups using a competitive entry method. The test group is given nutritional education and high caloric ONS (which can supplement 30% of the energy requirement), while the control group is given nutritional education and dietary instruction.Participants are followed up at 0, 1,2, 3, 6, and 12 months of enrollment. The investigators will collect dietary diaries, physical indicators, developmental quotient scores, quality of life measures, gut health, infectious disease-related questionnaires and safety indicators (blood biochemical indicators, urine routine) from children in both groups to comprehensively assess the effect of high caloric ONS intervention on physical growth, neuropsychological development levels and related aspects (gut health, immune function, quality of life, etc.) of malnourished children, as well as to conduct safety analyses.

Sample size:According to similar studies to date, a total of 800 people are recommended for this study.

Statistical analysis: Statistical analysis is performed using SAS 9.4. For continuous variables (height, weight, BMI-Z score, DQ score, etc.), statistical descriptions are performed using mean and standard deviation (conforming to normal distribution) or median and interquartile range (IQR); for categorical variables, statistical descriptions are performed using frequency and percentage; for the main efficacy indicators, mixed-effects models are used for efficacy evaluation indicators according to the principle of adjusted intentionality analysis (mITT). For the safety evaluation, the number, frequency and incidence of adverse events and reactions are calculated, and the positive abnormal changes of laboratory biochemical indexes such as blood routine, urine routine, liver and kidney function are counted. p value < 0.05 is considered statistically significant.

Ethical matters and data protection: The guardians of the children participating in the study will sign an informed consent form. This study is approved by the local ethics committee. Patients' names will be abbreviated and study data will be assigned a code which will then be provided to the investigator. Parental authorization for patient health information will remain in effect until the study is completed. After that, private information will be removed from the study records by the researcher.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 800
• Est. completion date: June 30, 2025
• Est. primary completion date: February 28, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Year to 3 Years

Eligibility

Inclusion Criteria:

• Aged 1-3 years

• BMI for Age Z-score<-2

• Height-for-age z score<-2

• Total daily energy intake<75% of recommended nutrient intake

• The child's guardian is willing to participate in this study and sign an informed consent form.

Exclusion Criteria:

• Chronic or severe infectious disease (e.g., chronic hepatitis, HIV or tuberculosis infection)

• Certain congenital or genetic diseases affecting physical growth and development (congenital heart disease, Down's syndrome, infantile anorexia nervosa, etc.), malignancies and use of drugs (diuretics, appetite stimulants, steroids and growth hormones, etc.)

• Severe gastrointestinal disorders (e.g., celiac disease, short bowel syndrome, inflammatory bowel disease, etc.)

• Acute and chronic respiratory/digestive tract infections within 2 weeks prior to enrollment

• Allergy or contraindication to any of the ingredients in the high-energy total nutrition formula used in this study

• Have used high-energy enteral nutrition preparations for the last 3 months

Related Conditions & MeSH terms

• Child Nutrition Disorders
• Malnourishment
• Malnutrition
• Malnutrition, Child
• Nutritional Deficiency
• Undernutrition

Intervention

Dietary Supplement:
• high caloric oral nutritional supplements
High caloric oral nutritional supplements (which can supplement 30% of the energy requirement) is given daily, and the recommended amount of energy and protein is referred to the 2013 Chinese Dietary Nutrient Reference Intake Table. At 6 months of enrollment, participants will be asked to evaluate whether to continue feeding according to the experimental group protocol or to stop to ensure proper nutritional intake.

Behavioral:
• nutritional education
After enrollment,health education information is pushed approximately every 4 weeks through the WeChat platform or/and short text messages to parents.
• dietary guidance
At follow-up visits at 0, 1, 2, 3, 6,and 12 months after enrollment, a professionally trained pediatrician give the participant's guardian dietary instructions appropriate to the age stage and physical condition of the child. Each session lasts approximately 10 minutes.

Locations

Country	Name	City	State
China	Baoji Maternity and Child Healthcare Hospital	Baoji	Shanxi
China	Children's Hospital of The Capital Institute of Pediatrics	Beijing	Beijing
China	Hunan Children's Hospital	Changsha	Hunan
China	Chengdu Women's and Children's Central Hospital,School of Medicine,University of Electronic Science and Technology of China	Chengdu	Sichuan
China	Growth, Development and Mental health of Children and Adolescence Center	Chongqing	Chongqing
China	Guangzhou Women and Children's Medical Center	Guangzhou	Guangdong
China	Guiyang Maternity and Child Health Care Hospital	Guiyang	Guizhou
China	Anhui Provincial Children's Hospital	Hefei	Anhui
China	Kunming Children's Hospital	Kunming	Yunnan
China	Jiangxi Maternal and Child Health Hospital	Nanchang	Jiangxi
China	Nanjing Maternity and Child Health Care Hospital	Nanjing	Jiangsu
China	Xianyang Children's Hospital	Xianyang	Shanxi

Sponsors (13)

Lead Sponsor

Collaborator

Children's Hospital of Chongqing Medical University

Anhui Provincial Children's Hospital, Baoji Maternity and Child Healthcare Hospital, Chengdu Women's and Children's Central Hospital, Children's Hospital of The Capital Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guiyang Maternity and Child Health Care Hospital, Hunan Children's Hospital, Jiangxi Maternal and Child Health Hospital, Kunming Children's Hospital, Nanjing Maternity and Child Health Care Hospital, Nestle Health Science, Xianyang Children's Hospital

Country where clinical trial is conducted

China, 

References & Publications (1)

Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, Dixon-Woods M, Aldcroft A, Doussau A, Grayling M, Kristunas C, Goldstein CE, Campbell MK, Girling A, Eldridge S, Campbell MJ, Lilford RJ, Weijer C, Forbes AB, Grimshaw JM. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018 Nov 9;363:k1614. doi: 10.1136/bmj.k1614. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	BMI for Age Z-score(BAZ)	Trained research assistants or health care practitioners obtain weight in kilograms and height in centimeters (mean of 3 consecutive measurements). Height and weight will be combined to report BMI in kg/m^2.Then, the BAZ is calculated using WHO2011v3.2.2 software.	at 6 months of enrollment
Secondary	Dietary Diary	Participants provide a dietary diary over an average two-day period through a WeChat app each visit. The app prompts participants to record and estimate details of all meals and snacks they consumed, especially formula used in the study.	at 0, 1, 2, 3, 6 and 12 months of enrollment
Secondary	BMI for Age Z-score(BAZ)	Trained research assistants or health care practitioners obtain weight in kilograms and height in centimeters (mean of 3 consecutive measurements). Height and weight will be combined to report BMI in kg/m^2.Then, the BAZ is calculated using WHO2011v3.2.2 software.	at 0, 1, 2, 3 and 12 months of enrollment
Secondary	Weight for Age Z-score(WAZ)	Trained research assistants or health care practitioners obtain weight in kilograms using a standardized approach. Weight is measured using a precision digital scale or mechanical scale(mean of 3 consecutive measurements). Then, the WAZ is calculated using WHO2011v3.2.2 software.	at 0, 1, 2, 3, 6 and 12 months of enrollment
Secondary	Height for Age Z-score(HAZ)	Trained research assistants or health care practitioners obtain height in centimeters using a standardized approach. Height is measured with a calibrated stadiometer(mean of 3 consecutive measurements). Then, the HAZ is calculated using WHO2011v3.2.2 software.	at 0, 1, 2, 3, 6 and 12 months of enrollment
Secondary	Gesell Developmental Scale Test	Mainly assesses participants in 5 areas:adaptive behavior, gross motor, fine motor, language behavior,personal-social behavior, the evaluation finally calculates the developmental quotient (DQ) of each area. Diagnostic criteria: DQ is more than or equal to 86 is normal, DQ is marginal between 76 and 85, DQ is mild mental retardation between 55 and 75, DQ is moderate mental retardation between 40 and 54, DQ is severe mental retardation between 25 and 39, and DQ is less than or equal to 25 is extremely severe mental retardation.	at 0, 6, and 12 months of enrollment
Secondary	Infants - Junior High School Students Social Competence Test (S-M test)	The scale, derived from the revised version of the Japanese Social Competence test (S-M test) and revised by a Chinese researcher, is applicable to children from 6 months of age to 14 years of age and includes 132 items in 6 sections with 7 starting ages, which are filled in item by item by parents or daily caregivers according to the appropriate age, with =10 being normal.	at 0, 6, and 12 months of enrollment
Secondary	Pediatric Quality of Life Inventory (PedsQL)	The quality of life of the participants is assessed using the Pediatric Quality of Life Inventory.The Infant Scale or Generic Core Scales is completed according to age.Scores are transformed on a scale from 0 to 100,with higher scores indicating better quality of life.	at 0, 6, and 12 months of enrollment
Secondary	the Chinese version of the World Health Organization Quality of Life-BREF (WHOQOL-BREF)	The quality of life of parents is assessed using the WHOQOL-BREF.The WHOQOL-BREF, comprises 26 items, two general items and 24 others, across the following four domains: physical (7 items), psychological (6 items), social (3 items), and environmental (8 items).Calculate the average score of all items in each domain, converted into a score of 4 to 20 or 0 to100 by two algorithms,with higher scores indicating better quality of life.	at 0, 6 and 12 months of enrollment
Secondary	Gut Health Questionnaire	A questionnaire is used to understand gut health, including entries on the Bristol Stool Scale (to assess stool status), the average number of bowel movements per day, and the frequency of bloating and abdominal pain.	at 0, 1,3, 6, and 12 months of enrollment
Secondary	Infectious Diseases Related Questionnaire	A infectious disease-related questionnaire is used to understand immune function, including the number and duration of upper respiratory tract infections, infectious diarrhea.	at 0, 1,3, 6, and 12 months of enrollment
Secondary	Blood Routine Test	Blood routine test is completed at 0, 6 and 12 months of enrollment for safety analysis.Includes the following parameters:white blood cell count,red blood cell count,hemoglobin,mean corpuscular hemoglobin concentration,platelet,standard deviation in red cell distribution width,coefficient variation of red blood cell volume distribution width,platelet distribution width,mean platelet volume,platelet larger cell ratio,thrombocytocrit,neutrophil ratio,lymphocyte ratio,monocyte ratio,eosinophil ratio,basophil ratio,neutrophil count,lymphocyte count,monocyte count,eosinophil count,basophil count.	at 0, 6 and 12 months of enrollment
Secondary	Liver Function Test	Liver function test is completed at 0, 6 and 12 months of enrollment for safety analysis.Includes the following parameters:total protein,albumin,globulin,alanineamino transferase,aspartate amino transferase,bilirubin,direct bilirubin,total bile acid,alkaline phosphatase,amma-glutamyl transpeptidase.	at 0, 6 and 12 months of enrollment
Secondary	Renal Function Test	Renal function test is completed at 0, 6 and 12 months of enrollment for safety analysis.Includes the following parameters:creatinine,blood urea nitrogen.	at 0, 6 and 12 months of enrollment
Secondary	Urine Routine Test	Urine routine test is completed at 0, 6 and 12 months of enrollment for safety analysis.Includes the following parameters:urinary bilirubin,urinary ketone bodies,blood,urinary white blood cells,urinary red blood cells,urinary sugar,urinary protein,urinary cast.	at 0, 6 and 12 months of enrollment